
Polymers for Pharmaceutical and Biomedical Applications
Fundamentals, Selection, and Preparation
- 1st Edition - January 16, 2024
- Imprint: Elsevier
- Editors: Vandana Patravale, John I. Disouza, Aliasgar Shahiwala
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 9 5 4 9 6 - 9
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 5 4 9 7 - 6
Polymers for Pharmaceutical and Biomedical Applications: Fundamentals, Selection, and Preparation supports the successful selection, design, and development of polymers with the… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quotePolymers for Pharmaceutical and Biomedical Applications: Fundamentals, Selection, and Preparation supports the successful selection, design, and development of polymers with the required properties and performance for a range of advanced pharmaceutical and biomedical applications. The book begins by introducing polymers for pharmaceutical and biomedical applications, examining classification, basic properties, structures, and grades. This is followed by in-depth chapters on synthesis and modification, characterization techniques, and dissolution and solubility of polymers for pharmaceutical applications. Key applications are highlighted, with chapters explaining the preparation of polymers for conventional dosage, modified drug delivery, conjugates, advanced drug and gene delivery, medical devices, pharmaceutical packaging, and more. Throughout the book, the aim is to provide accessible, step-by-step coverage supported by diagrams and case studies. This is a valuable resource for all those who are newly approaching the field of polymers and product development for pharmaceutical and biomedical applications. This includes researchers and advanced students across polymer science, pharmaceutical science, biomaterials, biomedicine, healthcare, and chemistry, and scientists and R&D professionals in an industrial setting.
- Explains fundamental concepts relating to the synthesis, modification, and characterization of polymers
- Guides the reader towards successful selection of polymer systems for specific target applications
- Addresses key challenges in this field that are supported by case studies and regulatory information
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Chapter 1 Pharmaceutical and biomedical polymers: Basics, modifications, and applications
- Abstract
- 1.1 Introduction
- 1.2 Advantages of polymers
- 1.3 Classification of polymers
- 1.4 Chemistry, properties, and applications of pharmaceutical and biomedical polymers
- 1.5 Conclusions
- References
- Chapter 2 Polymer synthesis and modification
- Abstract
- 2.1 Introduction
- 2.2 Methods of polymer synthesis
- 2.3 Polymer simulation and artificial intelligence in polymer synthesis
- 2.4 Conclusions
- References
- Further reading
- Chapter 3 Characterization of polymers
- Abstract
- 3.1 Introduction to essential characteristics of the polymers to be revealed
- 3.2 Solid-state characterization of polymers
- 3.3 Solution phase characterization
- 3.4 Interpenetrating polymer network
- 3.5 Biological characterization of polymers
- 3.6 Polymer-based biomaterial interaction with cells: In vitro characterization
- 3.7 Other methods in the characterization of polymers
- 3.8 Summary and future perspectives
- References
- Chapter 4 Polymer dissolution
- Abstract
- 4.1 Introduction to polymer dissolution and its importance
- 4.2 Mechanism of polymer dissolution
- 4.3 Factors affecting polymer dissolution
- 4.4 Polymer solubility and solubility parameters
- 4.5 Polymer dissolution models
- 4.6 Techniques to study polymer dissolution
- 4.7 Conclusions
- References
- Chapter 5 Pharmaceutical polymers in conventional dosage forms
- Abstract
- 5.1 Solid oral dosage forms
- 5.2 Solutions and liquid disperse systems
- 5.3 Semisolids
- 5.4 Transdermal drug delivery systems (TDDS)
- 5.5 Parenterals
- 5.6 Ophthalmics
- 5.7 Other dosage forms including nasal, buccal, rectal, and vaginal dosage forms
- 5.8 Polymers in cosmetic formulations
- References
- Chapter 6 Pharmaceutical polymers for modified drug delivery and controlled release
- Abstract
- 6.1 Introduction
- 6.2 Mechanisms of modified release
- 6.3 Polymers for oral, modified drug release systems
- 6.4 Mucoadhesive polymers for modified drug delivery
- 6.5 In situ gelling and depot/implant forming systems for controlled drug delivery
- References
- Chapter 7 Polymer conjugates
- Abstract
- 7.1 Polymer therapeutics
- 7.2 Polymer-drug conjugates
- 7.3 Nanoparticle-drug conjugates
- 7.4 Protein-polymer conjugates
- References
- Chapter 8 Polymers in advanced drug and gene delivery
- Abstract
- 8.1 Introduction to polymers
- 8.2 Classification of polymers for drug and gene delivery
- 8.3 Source of polymers
- 8.4 Polymeric NPs for drug and gene delivery
- 8.5 Engineered polymers and novel polymeric architectures
- 8.6 Amphiphilic polysaccharides as delivery systems
- 8.7 Polymer-drug conjugates
- 8.8 Smart polymers for cell therapy
- 8.9 Conclusions
- References
- Chapter 9 Polymers in medical devices and pharmaceutical packaging
- Abstract
- 9.1 Introduction
- 9.2 Polymers in medical devices
- 9.3 Polymers in pharmaceutical container closure systems
- 9.4 Conclusions
- References
- Chapter 10 Polymers for 3D cell culture and tissue engineering applications
- Abstract
- 10.1 Introduction
- 10.2 Techniques for developing 3D cell culture
- 10.3 Native ECM-based 3D cell culture for mimicking the native tissues
- 10.4 Polymers for manufacturing scaffolds
- 10.5 Polymer-based microspheres
- 10.6 Polymer-based hydrogels as bioinks for bioprinting
- 10.7 Standardization and quality control of bioinks
- 10.8 Conclusion
- References
- Chapter 11 Regulation of pharmaceutical polymers
- Abstract
- 11.1 Introduction
- 11.2 Polymeric biomaterial forms
- 11.3 Polymers as excipients
- 11.4 Impurity testing in polymers
- 11.5 Global regulatory assessment of polymers
- 11.6 The global pharmaceutical market
- 11.7 Emerging market overview
- 11.8 Registration requirements for emerging markets
- 11.9 Registration requirements for regulated markets like EU/UK/US
- 11.10 Polymers for packaging
- 11.11 Novel excipients and their regulatory status
- 11.12 Current regulatory status of novel excipients
- 11.13 Medical polymers
- 11.14 Medical device materials
- 11.15 Conclusions
- References
- Index
- Edition: 1
- Published: January 16, 2024
- Imprint: Elsevier
- No. of pages: 500
- Language: English
- Paperback ISBN: 9780323954969
- eBook ISBN: 9780323954976
VP
Vandana Patravale
JD
John I. Disouza
AS